U.S. Tech Hardware Stock News

NasdaqGM:AVBP
NasdaqGM:AVBPBiotechs

Is ArriVent BioPharma (AVBP) Offering Value After Recent Share Price Pullback?

Wondering if ArriVent BioPharma at around US$22.86 is offering fair value, or if the market is missing something in this biotech story? The stock has had a mixed run, with a 5.1% decline over the last week, a 0.4% return over the past month, and a 9.9% gain year to date, contributing to a 17.0% return over the last year. Recent attention on ArriVent BioPharma has centered on its position within the biotech space and how its pipeline prospects and funding profile compare with peers. This...
NasdaqGS:FIBK
NasdaqGS:FIBKBanks

Assessing First Interstate BancSystem (FIBK) Valuation After Mixed Recent Share Price Performance

First Interstate BancSystem (FIBK) shares closed at $32.28, with recent returns mixed across different timeframes. This may prompt investors to reassess the bank’s valuation, profitability profile and income potential. See our latest analysis for First Interstate BancSystem. The recent 15% 30 day share price decline and softer year to date return contrast with a 20% 1 year total shareholder return, suggesting near term momentum has cooled while longer term holders have still come out...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

How Investors Are Reacting To J.B. Hunt (JBHT) Margin Gains, Intermodal Strength and Buybacks Amid FMS Drag

In recent months, J.B. Hunt Transport Services reported operating margin expansion to 8.0% from 6.6% year over year, with operating income up 19%, supported by intermodal strength, cost initiatives, and sizeable 2025 share repurchases of about US$923.00 million. An interesting angle is the contrast between improved intermodal efficiency and 95% customer retention on one hand, and ongoing uncertainty around the weaker Final Mile Services segment on the other. With these margin gains and...
NYSE:NOC
NYSE:NOCAerospace & Defense

Is It Too Late To Consider Northrop Grumman (NOC) After Its Strong Share Price Run?

If you are wondering whether Northrop Grumman's current share price still offers value after a strong run, or if most of the opportunity is already priced in, this article focuses squarely on what you are paying versus what you might reasonably expect to get. With the stock at US$714.15 after a 21.9% return year to date and 48.3% over the last year, recent moves have sharpened the question of whether the current valuation still looks appealing or is becoming more demanding. Recent headlines...
NYSE:TNET
NYSE:TNETProfessional Services

TriNet Dividend Increase Tests Balance Between Shareholder Cash And Flexibility

TriNet Group's Board has approved an increase in the company's dividend. The new dividend level reflects management's view of TriNet Group's current financial position. This decision comes with TriNet Group (NYSE:TNET) shares trading at $36.83. For investors watching NYSE:TNET, the dividend move comes during a challenging share price record. The stock is at $36.83, with returns showing a 1.9% gain over the past 7 days but declines of 11.8% over 30 days, 35.6% year to date, 52.5% over 1...
NasdaqGM:ACMR
NasdaqGM:ACMRSemiconductor

Should ACMR’s Record Sales and Margin Compression Require Action From ACM Research (ACMR) Investors?

In its latest reported results, ACM Research delivered record annual revenue but saw a sharp gross margin contraction tied to product mix and competition, which contributed to an earnings miss. Despite these profitability pressures and ongoing China-related headwinds, management reiterated its ambition to reach a long-term revenue target of US$4.00 billion. We’ll now explore how the margin setback, despite record sales, may influence ACM Research’s previously optimistic investment...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

A Look At Power Solutions International (PSIX) Valuation After Strong Sales Growth And Earnings Beat

Recent earnings performance and what triggered investor attention Power Solutions International (PSIX) moved onto investors’ radar after reporting third quarter sales growth of 62% year over year and earnings that exceeded analyst expectations by about 22% to 23%. See our latest analysis for Power Solutions International. Despite recent earnings strength, the 1 month share price return of 42.13% and 7 day share price return of 10.35% decline suggest momentum has cooled, even though the 1 year...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

A Look At Sotera Health’s Valuation As Earnings Beat And Board Changes Reset Expectations

Why this earnings beat and board reshuffle matter for Sotera Health (SHC) Sotera Health (SHC) recently reported Q4 results that came in ahead of analyst expectations, supported by demand for its mission critical services and disciplined financial management, while also refreshing its board with a new independent director. See our latest analysis for Sotera Health. At a share price of US$13.56, Sotera Health has seen a 1 month share price return of around 21% decline and a 90 day share price...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

Assessing MoonLake Immunotherapeutics (MLTX) Valuation After Cormorant’s Large Share Purchase

Institutional buying sparks new attention on MoonLake Immunotherapeutics Cormorant Asset Management’s recent SEC filing, showing a purchase of over 2.3 million MoonLake Immunotherapeutics (NasdaqCM:MLTX) shares for an estimated US$27.86 million, has put the clinical stage biotech back on investor watchlists. See our latest analysis for MoonLake Immunotherapeutics. MoonLake’s recent 2.8% 1 day share price return to US$16.68 comes after a sharp sell off last year, with a 1 year total...
NasdaqGS:FSLR
NasdaqGS:FSLRSemiconductor

Assessing First Solar (FSLR) Valuation As Policy Uncertainty Offsets U.S. Demand Support

Recent research on First Solar (FSLR) has highlighted policy uncertainties and permitting delays weighing on its 2026 sales outlook, even as U.S. incentives and demand for domestically produced, non China solar modules support investor interest. See our latest analysis for First Solar. At a share price of US$199.65, First Solar has seen a 1 day share price return of 0.93% and a 90 day share price return decline of 25.22%. The 1 year total shareholder return of 55.42% contrasts with a 3 year...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

A Look At Enphase Energy (ENPH) Valuation After New Battery And Virtual Power Plant Partnerships

What Enphase’s new partnerships could mean for investors Enphase Energy (ENPH) has put partnerships at the center of its next phase in energy storage, working with Ensol in France and several US partners to expand residential batteries and virtual power plants. See our latest analysis for Enphase Energy. Recent partnerships around IQ Batteries and virtual power plants come as Enphase’s share price shows mixed momentum, with a 34.26% 90 day share price return alongside a 27.64% 1 year total...
NYSE:BLSH
NYSE:BLSHCapital Markets

Bullish Joins Midnight Alliance As Shares Show Strong Recent Momentum

Bullish (NYSE:BLSH) has joined Midnight Foundation's node operator alliance, supporting the rollout of the Kūkolu blockchain network. The company will act as a federated node operator for the upcoming privacy focused mainnet alongside partners such as Worldpay. The collaboration positions Bullish within the early governance and technical operation of the new blockchain ecosystem. Bullish enters this alliance with its shares at $39.6 and recent returns of 9.3% over the past week and 23.8%...
NasdaqGS:AVPT
NasdaqGS:AVPTSoftware

A Look At AvePoint (AVPT) Valuation After Launching Its AgentPulse AI Governance Platform

AvePoint (AVPT) put its AvePoint AgentPulse Command Center into general availability, expanding multicloud observability for Google Cloud and Microsoft 365. The move is aimed at AI agent governance, data security, and enterprise cost control. See our latest analysis for AvePoint. The AgentPulse launch comes as AvePoint’s 1 year total shareholder return shows a decline of around 31%, while the 3 year total shareholder return is more than double. Recent 90 day share price weakness suggests...
NYSE:NVO
NYSE:NVOPharmaceuticals

Has Novo Nordisk (NYSE:NVO) Fallen Too Far After Its 52% One Year Share Price Decline

If you are wondering whether Novo Nordisk's current share price still reflects its long term potential, you are not alone. This article focuses squarely on what the current valuation might be telling you. The stock last closed at US$37.08, after a 2.5% decline over the past week, a 24.9% decline over the past month, a 29.2% decline year to date and a 52.0% decline over the last year, while the 5 year return sits at 16.8%. Recent coverage has centered on how such a sharp 1 year decline...
NYSE:LEU
NYSE:LEUOil and Gas

Is It Too Late To Consider Centrus Energy (LEU) After Its Huge Three Year Rally?

Wondering if Centrus Energy at around US$205 a share still offers value, or if the best gains are already behind it? This article breaks down what the current price actually means for you. The stock has been volatile, with a 4.5% decline over the last 7 days and a 24.7% drop year to date. It still shows a 176.1% return over the past year and a very large 3-year gain of around 7x. Recent coverage has focused on Centrus Energy's role in the nuclear fuel supply chain and its position within the...
NYSE:ANET
NYSE:ANETCommunications

Arista Networks (ANET) Valuation Check After XPO Optics Launch And Renewed Analyst Attention

Arista Networks (ANET) is back in focus after unveiling its XPO optics module, a 12.8 Tbps liquid cooled design that targets AI heavy data centers, alongside fresh attention from Wall Street analysts. See our latest analysis for Arista Networks. The latest XPO optics news and renewed analyst attention come after a mixed set of short term moves, with a 7 day share price return of 1.66% and a 30 day share price return decline of 4.43%, while the 1 year total shareholder return of 64.23% and 5...
NasdaqGS:ECPG
NasdaqGS:ECPGConsumer Finance

A Look At Encore Capital Group (ECPG) Valuation After Strong Recent Share Price Momentum

Encore Capital Group stock: context for recent moves Encore Capital Group (ECPG) has drawn investor attention after a strong recent share move, with the stock closing at US$69.14 and showing double digit returns over the past month and past 3 months. See our latest analysis for Encore Capital Group. The recent 20.7% 1 month share price return and 26.8% 3 month share price return sit within a broader picture where the 1 year total shareholder return is around 100%, suggesting strong momentum...
NYSE:DELL
NYSE:DELLTech

Did Dell’s New Voice AI Partnership Quietly Reposition Dell Technologies' (DELL) Enterprise Infrastructure Narrative?

PENGUIN SOLUTIONS, Deepgram, and Dell Technologies recently completed a collaboration to build a production-ready AI infrastructure using Dell PowerEdge servers, PowerScale storage, and NVIDIA RTX PRO 6000 Blackwell Server Edition GPUs to support Deepgram’s real-time voice AI workloads. This three-way partnership underscores how Dell’s AI hardware is becoming a foundational layer for mission-critical, low-latency enterprise voice applications that demand strict data governance. We’ll now...
NasdaqGS:LILA
NasdaqGS:LILATelecom

Is Liberty Latin America (LILA) Offering Value After Recent Share Price Gains?

Wondering whether Liberty Latin America at around US$7.96 is priced for opportunity or already reflects the key information you care about? The stock has returned 5.3% over the last week, 1.5% over the past month, 9.6% year to date and 17.2% over the last year. The 3 year return is 2.4% and the 5 year return is a 41.4% decline. Recent coverage of Liberty Latin America has focused on its position within the broader telecom sector and how investors are reacting to its capital allocation and...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

Is IDEAYA Biosciences (IDYA) Priced Fairly After A 76.8% One-Year Share Gain?

If you are trying to work out whether IDEAYA Biosciences at around US$32.60 still offers value, the starting point is understanding how its current share price lines up against different valuation checks. The stock has seen a mixed return profile, with a 0.7% decline over the past week, a 6.0% gain over the last 30 days, a 3.7% decline year to date, and a 76.8% return over the past year. These moves sit against a backdrop of ongoing interest in IDEAYA Biosciences within the biotech space, as...
NYSE:CRCL
NYSE:CRCLSoftware

Is It Too Late To Consider Circle Internet Group (CRCL) After Its Recent Surge In Price?

If you are wondering whether Circle Internet Group at around US$128 per share is priced attractively or already stretched, you are not alone. The stock has seen strong recent returns, with a 12.4% move over the last week, 108.3% over the past 30 days, and 53.7% year to date. Recent coverage has focused on Circle Internet Group's position within the software space and how investors are responding to its profile in public markets. This helps explain the sharp moves in the share price...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

A Look At ADP’s Valuation As Positive Guggenheim Initiation Meets Upgraded 2026 Growth Outlook

Automatic Data Processing (ADP) is back on investor radar after Guggenheim initiated coverage with a positive view. Management also lifted its fiscal 2026 revenue and earnings outlook, supported by ongoing share repurchases. See our latest analysis for Automatic Data Processing. Despite Guggenheim's positive initiation and upgraded fiscal 2026 guidance, ADP's share price is currently US$210.66, with a 90 day share price return of an 18.33% decline and a 1 year total shareholder return of a...
NYSE:M
NYSE:MMultiline Retail

Macy's (M) Is Up 5.1% After Beating Q4 Targets And Raising 2026 Guidance - What's Changed

In March 2026, Macy’s, Inc. reported fourth-quarter 2025 sales of US$7,639 million and net income of US$507 million, with full-year net income of US$642 million on revenue of US$22,621 million, while issuing 2026 net sales guidance of US$21.40 billion to US$21.65 billion. The company highlighted an inflection in performance with positive comparable sales across its banners, expanded “Reimagine” store remodels, further planned store exits, and continued share repurchases, signaling meaningful...
NYSE:AM
NYSE:AMOil and Gas

A Look At Antero Midstream (AM) Valuation After Its Recent Share Price Surge

Recent performance and business snapshot Antero Midstream (AM) has caught investor attention after a month with a 7.6% share price return and a past 3 months move of 31.8%, prompting a closer look at its fundamentals. The company operates midstream energy assets in the Appalachian Basin across two main segments: Gathering and Processing, and Water Handling, serving Antero Resources’ natural gas and NGL production in West Virginia and Ohio. Antero Midstream reports annual revenue of...